Phathom Pharmaceuticals Inc (PHAT)
Healthcare
Biotechnology
9.00 $
+2.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Phathom Pharmaceuticals Inc (PHAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -167 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -1.0 | -37 | -70 | -148 | -147 | -138 | -267 | -167 | |
| 0.0 | 0.0 | 0.3 | 0.5 | 0.6 | 0.6 | 0.8 | 0.6 | |
| – | 0.4 | 5.8 | 17 | 24 | 45 | 24 | 29 | |
| 0.1 | 228 | 6.1 | 19 | 43 | – | – | – | |
| 0.2 | -9.5 | 52 | -27 | 5.4 | -14 | -15 | -12 | |
| 0.1 | 25 | 1.0 | 0.3 | 1.0 | 1.6 | 0.1 | 0.2 | |
| -25 | -25 | -1.0 | -0.3 | -1.0 | -1.6 | -0.1 | -0.2 | |
| 0.0 | 191 | 0.6 | 1.9 | – | – | – | – | |
| 1.9 | 113 | 25 | 43 | 95 | 39 | 59 | 0.0 | |
| 1.9 | 305 | 114 | 45 | 120 | 368 | 183 | -0.3 | |
| 0.9 | 243 | 44 | -104 | -28 | 228 | -84 | -167 | |
| -1.0 | -62 | -71 | -149 | -148 | -139 | -267 | -167 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.